Literature DB >> 5718504

Modification of the graft-versus-host syndrome by anti-lymphocyte serum treatment of the host.

J L Boak, R K Dagher, J M Corson, R E Wilson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5718504      PMCID： PMC1578972     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  9 in total

1.  IMMUNOLOGICAL MODIFICATIONS OF GRAFT-VERSUS-HOST REACTION.

Authors:  J G HOWARD
Journal:  Guys Hosp Rep       Date:  1963

2.  Quantitative study of the granulopectic activity of the reticulo-endothelial system. II. A study of the kinetics of the R. E. S. in relation to the dose of carbon injected; relationship between the weight of the organs and their activity.

Authors:  G BIOZZI; B BENACERRAF; B N HALPERN
Journal:  Br J Exp Pathol       Date:  1953-08

3.  Site of action of antilymphocyte globulin.

Authors:  W J Martin; J F Miller
Journal:  Lancet       Date:  1967-12-16       Impact factor: 79.321

4.  Activity of lymphoid tissues from antilymphocyte-serum-treated mice.

Authors:  J L Boak; M Fox; R E Wilson
Journal:  Lancet       Date:  1967-04-08       Impact factor: 79.321

5.  Further experiments on the action of antilymphocytic antiserum.

Authors:  R H Levey; P B Medawar
Journal:  Proc Natl Acad Sci U S A       Date:  1967-08       Impact factor: 11.205

6.  Studies on heterologous anti-lymphocyte serum in mice. I. In vitro and in vivo properties.

Authors:  J G Gray; A P Monaco; M L Wood; P S Russell
Journal:  J Immunol       Date:  1966-02       Impact factor: 5.422

7.  Effects of heterologous anti-lymphocyte serum on the distribution of 51-Cr-labelled lymph node cells in mice.

Authors:  R N Taub; E M Lance
Journal:  Immunology       Date:  1968-11       Impact factor: 7.397

8.  Modification of the graft-versus-host syndrome by anti-lymphocyte serum treatment of the donor.

Authors:  J L Boak; R E Wilson
Journal:  Clin Exp Immunol       Date:  1968-10       Impact factor: 4.330

9.  The use of immunologically competent cells in the treatment of cancer: experiments with a transplantable mouse tumour.

Authors:  M F WOODRUFF; M O SYMES
Journal:  Br J Cancer       Date:  1962-12       Impact factor: 7.640
  9 in total
  2 in total

1.  Modification of the graft-versus-host syndrome by anti-lymphocyte serum treatment of the donor.

Authors:  J L Boak; R E Wilson
Journal:  Clin Exp Immunol       Date:  1968-10       Impact factor: 4.330

2.  Effect of antilymphocyte serum on macrophage activity.

Authors:  M J Chare; J L Boak
Journal:  Clin Exp Immunol       Date:  1970-05       Impact factor: 4.330
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.